C.R. Bard, 4.4% 15jan2021, USD (FIGI BBG001BN4HM8, WKN A1GKE8)
国内債券
国内債券
|
C. R. Bard products fall into four general therapeutic categories: vascular, oncology, urology, and surgical specialties. Among other things, the company makes stents, catheters, and guidewires used in angioplasties and other vascular procedures; catheters for delivering ...
C. R. Bard products fall into four general therapeutic categories: vascular, oncology, urology, and surgical specialties. Among other things, the company makes stents, catheters, and guidewires used in angioplasties and other vascular procedures; catheters for delivering chemotherapy treatments; and urology catheters and products used to treat urinary incontinence. Its line of specialty surgical tools, made by subsidiary Davol, includes devices used in laparoscopic and orthopedic procedures and for hernia repair
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡